NCT02571036 2023-12-13A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced MalignanciesDeciphera Pharmaceuticals, LLCPhase 1 Completed282 enrolled
NCT00481559 2014-01-17Treatment Protocol of Voraxaze for Patients Experiencing or at Risk of Methotrexate ToxicityBTG International Inc.Approved for marketing